Knowles et al. has identified that alterations in pathway components PIK3CA, PTEN, AKT1 and TSC1 in bladder cancer are significantly related to tumor phenotype and clinical behavior [30]. This evidence concerns the gene AKT1 and urinary bladder carcinoma.